Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
- 15 March 1999
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 45 (6) , 668-679
- https://doi.org/10.1016/s0006-3223(98)00237-6
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The Basal Ganglia and Cognitive Pattern GeneratorsSchizophrenia Bulletin, 1997
- Functional and Anatomical Aspects of Prefrontal Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesisNeuroscience & Biobehavioral Reviews, 1997
- The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?Life Sciences, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysisLife Sciences, 1988
- Dissociative AnesthesiaAnesthesia & Analgesia, 1966